Dec 29 (Reuters) - Regeneus Ltd (RGS)
- Regeneus collaborates with agc asahi for exclusive manufacture of progenza stem cell technology for Japanese market
- Regeneus and AGC establish 50/50 joint venture for exclusive clinical development and commercialisation of progenza
- regeneus to receive us$16.5m with us$5.5m upfront and us$11m in specified milestone payments